Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Katano

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|October 9, 2023
Independent Link Between Use of Mineralocorticoid Receptor Antagonists and Muscle Wasting in Heart Failure Patients Not Receiving Renin-Angiotensin System InhibitorsRyo Numazawa, Satoshi Katano, Toshiyuki Yano, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 4, 2020
[Association Suvorexant and Ramelteon Use with the Risk of Falling: A Retrospective Case-control Study]Tomoyuki Ishigo, Ryo Takada, Fuki Kondo, et al.
Frontiers in Cardiovascular Medicine|January 6, 2023
Loss of perceived social role, an index of social frailty, is an independent predictor of future adverse events in hospitalized patients with heart failureAyako Watanabe, Satoshi Katano, Toshiyuki Yano, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2023
Optimal serum 25-hydroxyvitamin D level to prevent sarcopenia in patients with heart failure: Insights from a dose-response relationshipRyohei Nagaoka, Satoshi Katano, Toshiyuki Yano, et al.
ESC Heart Failure|August 1, 2025
Diagnostic value of computed tomography-based muscle quality and metabolic signatures in heart failure with sarcopeniaWataru Kawaharata, Hidemichi Kouzu, Keishi Ogura, et al.
European Journal of Cardiovascular Nursing|August 26, 2023
Development and validation of osteoporosis risk assessment score in patients with heart failure: comparison with the osteoporosis self-assessment tool for AsiansRyo Numazawa, Satoshi Katano, Toshiyuki Yano, et al.
ESC Heart Failure|May 18, 2021
Does renin-angiotensin system inhibition have impacts on muscle mass and bone mineral density in heart failure patients?Satoshi Katano, Toshiyuki Yano, Masaki Shimizu, et al.
ESC Heart Failure|December 13, 2023
Relationship between serum iron level and physical function in heart failure patients is lost by presence of diabetesKatsuhiko Ohori, Toshiyuki Yano, Satoshi Katano, et al.
ESC Heart Failure|May 5, 2024
Associations between in-hospital daily protein intake and adverse clinical outcomes in older patients with heart failureSatoshi Katano, Toshiyuki Yano, Kotaro Yamano, et al.
Drugs & Aging|June 16, 2023
Independent Association Between Use of Proton Pump Inhibitors and Muscle Wasting in Patients with Heart Failure: A Single-Center, Ambispective, Observational StudyKatsuhiko Ohori, Toshiyuki Yano, Satoshi Katano, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Circulation Journal : Official Journal of the Japanese Circulation Society|October 9, 2023
Independent Link Between Use of Mineralocorticoid Receptor Antagonists and Muscle Wasting in Heart Failure Patients Not Receiving Renin-Angiotensin System InhibitorsRyo Numazawa, Satoshi Katano, Toshiyuki Yano, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 4, 2020
[Association Suvorexant and Ramelteon Use with the Risk of Falling: A Retrospective Case-control Study]Tomoyuki Ishigo, Ryo Takada, Fuki Kondo, et al.
Frontiers in Cardiovascular Medicine|January 6, 2023
Loss of perceived social role, an index of social frailty, is an independent predictor of future adverse events in hospitalized patients with heart failureAyako Watanabe, Satoshi Katano, Toshiyuki Yano, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2023
Optimal serum 25-hydroxyvitamin D level to prevent sarcopenia in patients with heart failure: Insights from a dose-response relationshipRyohei Nagaoka, Satoshi Katano, Toshiyuki Yano, et al.
ESC Heart Failure|August 1, 2025
Diagnostic value of computed tomography-based muscle quality and metabolic signatures in heart failure with sarcopeniaWataru Kawaharata, Hidemichi Kouzu, Keishi Ogura, et al.
European Journal of Cardiovascular Nursing|August 26, 2023
Development and validation of osteoporosis risk assessment score in patients with heart failure: comparison with the osteoporosis self-assessment tool for AsiansRyo Numazawa, Satoshi Katano, Toshiyuki Yano, et al.
ESC Heart Failure|May 18, 2021
Does renin-angiotensin system inhibition have impacts on muscle mass and bone mineral density in heart failure patients?Satoshi Katano, Toshiyuki Yano, Masaki Shimizu, et al.
ESC Heart Failure|December 13, 2023
Relationship between serum iron level and physical function in heart failure patients is lost by presence of diabetesKatsuhiko Ohori, Toshiyuki Yano, Satoshi Katano, et al.
ESC Heart Failure|May 5, 2024
Associations between in-hospital daily protein intake and adverse clinical outcomes in older patients with heart failureSatoshi Katano, Toshiyuki Yano, Kotaro Yamano, et al.
Drugs & Aging|June 16, 2023
Independent Association Between Use of Proton Pump Inhibitors and Muscle Wasting in Patients with Heart Failure: A Single-Center, Ambispective, Observational StudyKatsuhiko Ohori, Toshiyuki Yano, Satoshi Katano, et al.
Pageof 6